申请人:Bleicher Konrad
公开号:US20060089367A1
公开(公告)日:2006-04-27
Provided are compounds of the formula I:
and pharmaceutically acceptable salts thereof, processes for making said compounds and pharmaceutically acceptable salts thereof, pharmaceutical compositions comprising said compound and pharmaceutically acceptable salts thereof, and methods of using said compounds. The compounds are useful for the treatment and/or prophylaxis of diseases which are associated with the modulation of CB1 receptors.
提供的是以下式I的化合物:
及其药学上可接受的盐,制备该化合物及其药学上可接受的盐的方法,包含该化合物及其药学上可接受的盐的药物组合物,以及使用该化合物的方法。这些化合物对于治疗和/或预防与CB1受体调节相关的疾病是有用的。